Aurora Kinases in Ocular Malignancies: Functional Significance and Potential Implications

Area of Science:

• Ophthalmology
• Oncology
• Molecular Biology

Background:

• Ocular malignancies are rare, with limited treatment options primarily involving chemotherapy, radiation, and surgery.
• These rare tumors have historically received less research attention compared to other cancers.
• Recent research focuses on molecular pathways to develop targeted therapies for eye cancers.

Purpose of the Study:

• To review the role of aurora kinases (AURKs) in ocular tumor progression.
• To discuss the potential of targeting AURKs, specifically AURKA and AURKB, as a therapeutic strategy for retinoblastoma (RB) and uveal melanoma (UM).

Main Methods:

• Literature review focusing on aurora kinase function in normal and cancer cells.
• Analysis of AURK dysregulation in ocular malignancies, including RB and UM.
• Exploration of current therapeutic approaches for aurora kinase inhibition.

Main Results:

• Aurora kinases (AURKA and AURKB) are critical regulators of tumor progression in RB and UM.
• Dysregulation of AURKs is implicated in the development and progression of these ocular cancers.
• Aurora kinase inhibition shows therapeutic potential for treating RB and UM.

Conclusions:

• Targeting AURKA and AURKB represents a novel therapeutic avenue for rare ocular malignancies.
• Further research into aurora kinase inhibition could lead to improved treatment efficacy for patients with RB and UM.
• Understanding the molecular drivers of ocular cancers is crucial for developing effective targeted therapies.